Indian Institute of Technology-Kanpur Collaborates With I2Cure For Future-ready Research On Molecular Iodine Based Products

New Delhi: The Indian Institute of Technology-Kanpur (IIT-K) has collaborated with I2Cure (P) Ltd, a ‘Make in India for the world’ Biotech company for all future research on Molecular iodine-based products that would be undertaken by the Biological Sciences & Bioengineering wing of IIT-K (https://www.iitk.ac.in/bsbe/). I2Cure is the first Biotechnology Company in the world to produce Molecular Iodine-based i2cure BioShield’, which is a broad-spectrum antimicrobial with proven efficacy of 99.999% against the SARS2 Covid virus.

 

Under the terms of the agreement, I2Cure future products would be incubated at IIT-Kanpur. The relationship would be of the equity partners, and validations of Dr. Jack Kessler’s global research would be done for Indian conditions at IIT-K. IIT-K would also work with I2Cure to develop new ‘Made in India’ products for global markets, especially in tackling long-term problems in the space of Human Preventive Health, Veterinary science (FMD, Bovine Mastitis, Dermatitis), and Agri products. Conservative estimates point to more than $15 billion being added, per annum, to the income of farmers owing to the Biocidal & fungicidal benefits of Molecular Iodine preventives. All of the research and advancement would be performed under the guidance of IIT- K thought leaders namely:

Dr. Ganesh. S (Neurobiology of disorders, stress biology, and human genetics)

Dr. Ashok Kumar (Downstream processing; affinity interactions and cell separations; nanotechnology; biomaterials; tissue engineering)

Dr. Amitabha Bandopadhyay (Skeletal development and differentiation)

 

Stating on this momentous occasion, Mr. Anil Kejriwal, Founder Chairman of I2Cure shared, “I am delighted to partner my alma mater, IIT-Kanpur for research and innovation on future-ready preventive & curative products. It gives us great pleasure to be associated with an institution that is regarded as the gold standard among IITs. We would jointly be happy to contribute towards the vision of the Hon’ble Prime Minister of India to double Agricultural income as well as become a $5 Trillion economy. I2cure would ‘Make in India’ for the world.

Adding to it, (Prof.) Dr. Ashok Kumar, BSBE (Biological Sciences & Bioengineering at IIT Kanpur) added, “We are thrilled to welcome one of our 50 most distinguished alumni back to the campus & work towards creating lasting solutions for humans, bovine as well as agricultural problems plaguing India & the world. We’re excited about the prospects of IIT-K researched and curated solutions getting global attention. Our faculty & research scholars are also excited about mutually sharing knowledge with acclaimed scientists like Dr. Jack Kessler. IIT-K is known for its ‘intensive and cutting edge research’ approach and we’re confident of partnering other Indian Institutions and Govt. labs to lead India into the next leap”.

 

Dr. Kessler is a multiple patent holder with more than 3 decades of research in Iodine technology (https://patents.justia.com/inventor/jack-kessler) and has isolated, stabilized, and patented molecular Iodine (I2) which could potentially be 500 times more efficacious than the current Povidone-iodine. Not only does the Molecular Iodine-based BioShield protect against Covid, but is effective against all Bacterial, Fungal, Viral threats, Tuberculosis, Tinea, and all other skin diseases.

 

Comments are closed.